Primary Hyperparathyroidism Clinical Trial
Official title:
The Effect of Quadriceps Femoris Muscle Fatigue Protocol on Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism
Verified date | December 2023 |
Source | Recep Tayyip Erdogan University Training and Research Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate how Quadriceps Femoris muscle fatigue protocol affect the spatio-temporal gait parameters, gait symmetry and balance in individuals with primary hyperparathyroidism before and after parathyroidectomy. Study group will consist of 20 subjects with primary hyperparathyroidism (PHPT) and control group will consist of 20 healthy subjects.
Status | Completed |
Enrollment | 40 |
Est. completion date | August 27, 2023 |
Est. primary completion date | May 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 45 Years to 65 Years |
Eligibility | Inclusion Criteria: - PHPT group, include cases with a Primary Hyperparathyroidism - Control group consists of healthy adults with the similar demographic characteristics as study group. Exclusion Criteria: - The presence of osteoarticular deformities - Walking with assist device - Having a neurological disease that may affect the performance - To have significant and irreversible visual deficits - The body mass index (BMI) is greater than> 40 kg / m² - There is an inability to prevent any of the tests - Individuals with cancer history and chemotherapy (over the last 5 years) - Plasma creatinine level> 150 µmol / L - Use of Cinacalcet or Etalpha - Having a history of diabetes mellitus |
Country | Name | City | State |
---|---|---|---|
Turkey | Ankara Education and Research Hospital | Ankara | Cankaya |
Lead Sponsor | Collaborator |
---|---|
Recep Tayyip Erdogan University Training and Research Hospital | Ankara Education and Research Hospital, Hacettepe University |
Turkey,
Rolighed L, Rejnmark L, Sikjaer T, Heickendorff L, Vestergaard P, Mosekilde L, Christiansen P. No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial. Eur J Endocrinol. 2015 May;172(5):609-17. doi: 10.1530/EJE-14-0940. Epub 2015 Feb 2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Step Length | It is measured along the length of the walkway, from the heel center of the current footprint to the heel center of the previous footprint on the opposite foot.The unit of measure is centimeters. | 1 week | |
Secondary | Stride Length | It is measured on the line of progression between the heel points of two consecutive footprints of the same foot (left to left, right to right). The unit of measure is centimeters. | 1 week | |
Secondary | Static Balance Assessment | The Romberg test will use to assessment for diagnose sensory ataxia, a gait disturbance caused by abnormal proprioception involving information about the location of the joints. The Static Balance Assessment of the individuals in the PHPT group were assessed before and 3 months after Parathyroidectomy. | 1 week | |
Secondary | Dynamic Balance Assessment | To determine fall risk and measure the progress of balance, sit to stand, and walking Timed Up and Go Test will use. The Dynamic Balance Assessment of the individuals in the PHPT group were assessed before and 3 months after Parathyroidectomy. | 1 week | |
Secondary | Fatigue Severity | The fatigue level that individuals perceived during the performance was recorded using the Fatigue Severity Scale. This is a nine-items questionnaire that assesses the effect of fatigue on daily living. Each item is a statement on fatigue that the subject rates from 1, ' strongly disagree ' to 7, ' strongly agree '. | 1 week | |
Secondary | Functional Capacity | 6 Minute Walk test was used to evaluate the functional capacity. The test was performed in a corridor on a flat hard surface of 30 m in length in a straight line. Before the examination, the patient rested for 10 min in a sitting position. It is calculated by measuring the distance that the person walks at the end of this period by asking the person to walk for 6 minutes along a 30 m corridor. In cases of chest pain, dyspnea, leg cramps, excessive fatigue, sweating and wilting, the test should be terminated immediately. The clinician supervising the test instructed the subject on the walking technique and the possibility of taking a rest. At one-minute intervals during the test, the participant received information about the time remaining until the end of the test. | 1 week | |
Secondary | Step Width | It is measured from the midline midpoint of the current footprint to the midline midpoint of the previous footprint on the opposite foot.The unit of measure is centimeters. | 1 week | |
Secondary | Foot Progression Angle | It is the angle between the line of progression and the midline of the footprint. This angle is zero if the geometric mid- line of the footprint is parallel to the line of progression; positive, toe-out, when the mid-line of the footprint is outside the line of progression and negative, toe-in, when inside the line of progression. The unit of measure is degrees. | 1 week | |
Secondary | Speed | It is obtained after dividing the distance traveled by the ambulation time. It is expressed in centimeters per second (cm/sec) | 1 week | |
Secondary | Cadence | The rate at which a person walk, expressed in steps per minute (step/min). The average cadence is 100 - 115 steps/min. | 1 week | |
Secondary | Percentage of Double Support | It is the amount of time that a person spends with both feet on the ground during one gait cycle. It is presented as a percentage of the gait cycle time (% gait cycle). The percentage of time spent in double support decreases as the speed of walking increases. | 1 week | |
Secondary | Percentage of Stance | The stance phase is the weight bearing portion of each gait cycle. It is initiated by heel contact and ends with toe off of the same foot. It is the time elapsed between the first contact and the last contact of two consecutive footfalls on the same foot. It is also presented as a percentage of the gait cycle time (% gait cycle) | 1 week | |
Secondary | Percentage of Swing | It is initiated with toe off and ends with heel strike. It is the time elapsed between the last contact of the current footfall to the first contact of the next footfall on the same foot. It is expressed in seconds (sec) and it is also presented as a percent of the gait cycle (% gait cycle) of the same foot. The Swing Time is equal to the Single Support time of the opposite foot. | 1 week | |
Secondary | Gait Symmetry | It's calculated in order to evaluate symmetry and bilateral coordination of gait. The Symmetry Index and Symmetry Angle are interpreted as a complete symmetry if the result is 0. Evaluation of asymmetries observed in the spatio-temporal characteristics, a deviation of at least 10% from the 0 value for exact symmetry. | 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03931109 -
Circulating miRNA in Primary Hyperparathyroidism
|
||
Completed |
NCT04305561 -
Preoperative Localization Strategies in Primary Hyperparathyroidism
|
N/A | |
Recruiting |
NCT03052075 -
Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism
|
||
Completed |
NCT03774771 -
Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism
|
Phase 2 | |
Recruiting |
NCT02854345 -
Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera
|
N/A | |
Completed |
NCT01222026 -
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
|
Phase 4 | |
Recruiting |
NCT00973336 -
Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
|
Phase 2 | |
Completed |
NCT01530919 -
Minimally Invasive Radioguided Parathyroidectomy
|
N/A | |
Recruiting |
NCT03605472 -
Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism
|
N/A | |
Completed |
NCT01306656 -
Vitamin D Repletion in Primary Hyperparathyroidism
|
Phase 4 | |
Terminated |
NCT00961701 -
Lipids Profile in Primary Hyperparathyroidism
|
N/A | |
Completed |
NCT00432939 -
Primary Hyperparathyroidism: Non-classical Manifestations
|
N/A | |
Completed |
NCT00522028 -
Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial
|
N/A | |
Recruiting |
NCT04969926 -
Natural History Study of Parathyroid Disorders
|
||
Recruiting |
NCT03039439 -
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
|
||
Not yet recruiting |
NCT03732157 -
Feasibility of Parathyroidectomy With Exploration of 4 Parathyroid Glands in Outpatients
|
||
Completed |
NCT01996072 -
EC17 for Intraoperative Imaging for Parathyroidectomy
|
Phase 1 | |
Completed |
NCT01460030 -
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
|
Phase 3 | |
Enrolling by invitation |
NCT04085419 -
Osteoporosis in Primary Hyperparathyroidism
|
Phase 4 | |
Recruiting |
NCT03935984 -
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
|
Phase 4 |